School of Optometry and Vision Science, New Zealand National Eye Centre, The University of Auckland, New Zealand.
Department of Ophthalmology, New Zealand National Eye Centre, The University of Auckland, New Zealand.
Cont Lens Anterior Eye. 2018 Feb;41(1):88-92. doi: 10.1016/j.clae.2017.09.004. Epub 2017 Sep 30.
Better understanding of the pathophysiology of meibomian gland dysfunction (MGD) has provided the opportunity to develop treatments which could be tailored for specific presentations of MGD. This study sought to directly compare treatment effectiveness for three current therapies across differing levels of MG dropout.
Subjects (n=81), grouped by infrared meibography dropout proportions, into either no (control), mild, or pronounced MG dropout, were randomised to receive treatment with a latent heat device (n=25), liposomal spray (n=28), or heated warm compress (n=28). A battery of tear film measures was performed, pre- and post-application of treatment, and compared by treatment type and MG severity.
Symptoms correlated with MG dropout proportions (r=0.618, p<0.001). Following treatment, non-invasive tear breakup time improved (p=0.010), independent of treatment type (p=0.131). The improvement was significant only in the pronounced MGD group (+4.32 ±1.15s, p=0.008), however, following treatment, the mild group was no longer distinct from the control group (p=0.843). Lipid layer grade (LLG) also improved following treatment (p<0.009), but again was not specific to treatment type (p=0.349). All three severity groups showed an improvement in LLG, with 49.3% of participants showing an improvement of at least one grade, and none showing decreased LLG.
Increased LLG across all three treatment groups suggests that all methods increase meibum outflow to the tear film, resulting in a thicker lipid layer after treatment. These results suggest that all three treatments are effective in improving tear film quality, independent of MGD severity based either on symptoms or based on gland dropout.
对睑板腺功能障碍(MGD)病理生理学的更好理解为开发可针对 MGD 特定表现形式定制的治疗方法提供了机会。本研究旨在直接比较三种当前疗法在不同 MG 缺失程度下的治疗效果。
根据红外睑板腺照相术的缺失比例,将受试者(n=81)分为无(对照组)、轻度或明显 MG 缺失组,随机接受潜热装置(n=25)、脂质体喷雾(n=28)或加热温敷(n=28)治疗。在治疗前和治疗后进行一系列泪膜测量,并根据治疗类型和 MG 严重程度进行比较。
症状与 MG 缺失比例相关(r=0.618,p<0.001)。治疗后,非侵入性泪膜破裂时间(NIBUT)改善(p=0.010),与治疗类型无关(p=0.131)。改善仅在明显 MGD 组中显著(+4.32±1.15s,p=0.008),但治疗后,轻度组与对照组无差异(p=0.843)。脂质层等级(LLG)治疗后也有所改善(p<0.009),但也与治疗类型无关(p=0.349)。所有三个严重程度组的 LLG 均有所改善,49.3%的参与者至少改善了一个等级,没有一个等级的 LLG 降低。
所有三个治疗组的 LLG 均增加表明所有方法均增加了睑脂向泪膜的排出,治疗后脂质层更厚。这些结果表明,所有三种治疗方法均有效改善泪膜质量,无论基于症状还是基于腺体缺失,MGD 严重程度均无关。